Drug Enforcement Administration October 2010 – Federal Register Recent Federal Regulation Documents

Schedules of Controlled Substances: Placement of Propofol Into Schedule IV
Document Number: 2010-27193
Type: Proposed Rule
Date: 2010-10-27
Agency: Drug Enforcement Administration, Department of Justice
This proposed rule is issued by the Deputy Administrator of the Drug Enforcement Administration (DEA) to place the substance propofol, including its salts, isomers, and salts of isomers whenever the existence of such salts, isomers, and salts of isomers is possible, into schedule IV of the Controlled Substances Act (CSA). This proposed action is based on a recommendation from the Assistant Secretary for Health of the Department of Health and Human Services (DHHS) and on an evaluation of the relevant data by DEA. If finalized, this action would impose the regulatory controls and criminal sanctions of schedule IV on those who handle propofol and products containing propofol.
East Main Street Pharmacy; Affirmance of Suspension Order
Document Number: 2010-27096
Type: Notice
Date: 2010-10-27
Agency: Drug Enforcement Administration, Department of Justice
George Mathew, M.D.; Denial of Application
Document Number: 2010-27094
Type: Notice
Date: 2010-10-27
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-27037
Type: Notice
Date: 2010-10-26
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2010-27035
Type: Notice
Date: 2010-10-26
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2010-27032
Type: Notice
Date: 2010-10-26
Agency: Drug Enforcement Administration, Department of Justice
Steven B. Brown, M.D.; Revocation of Registration
Document Number: 2010-27031
Type: Notice
Date: 2010-10-26
Agency: Drug Enforcement Administration, Department of Justice
Gilbert Eugene Johnson, M.D.; Revocation of Registration
Document Number: 2010-27028
Type: Notice
Date: 2010-10-26
Agency: Drug Enforcement Administration, Department of Justice
Lincoln Pharmacy; Revocation of Registration
Document Number: 2010-27026
Type: Notice
Date: 2010-10-26
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2010-27025
Type: Notice
Date: 2010-10-26
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2010-27023
Type: Notice
Date: 2010-10-26
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-27021
Type: Notice
Date: 2010-10-26
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-27019
Type: Notice
Date: 2010-10-26
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-27018
Type: Notice
Date: 2010-10-26
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-26469
Type: Notice
Date: 2010-10-20
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-26468
Type: Notice
Date: 2010-10-20
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-26456
Type: Notice
Date: 2010-10-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2010-26454
Type: Notice
Date: 2010-10-20
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-26450
Type: Notice
Date: 2010-10-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2010-26447
Type: Notice
Date: 2010-10-20
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances; Notice of Application
Document Number: 2010-26445
Type: Notice
Date: 2010-10-20
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-26443
Type: Notice
Date: 2010-10-20
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-26440
Type: Notice
Date: 2010-10-20
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Application
Document Number: 2010-25849
Type: Notice
Date: 2010-10-14
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2010-25540
Type: Notice
Date: 2010-10-12
Agency: Drug Enforcement Administration, Department of Justice
Manufacturer of Controlled Substances; Notice of Registration
Document Number: 2010-25539
Type: Notice
Date: 2010-10-12
Agency: Drug Enforcement Administration, Department of Justice
Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies
Document Number: 2010-25136
Type: Rule
Date: 2010-10-06
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) is issuing this statement of policy to provide guidance under existing law regarding the proper role of a duly authorized agent of a DEA-registered individual practitioner in connection with the communication of a controlled substance prescription to a pharmacy.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.